Amneal Pharmaceuticals (AMRX) FCF Margin (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted FCF Margin of 6.52% for Q2 2026, down 34.99% on a QoQ basis from 4.83% in Q1 2026, and down 1494.0% year-over-year from 0.47% in Q2 2025.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) FCF Margin (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals has reported FCF Margin for 10 years, with the latest figure at 6.52% in Q2 2026.
- On a quarterly basis, FCF Margin fell 1494.0% year-over-year to 6.52% in Q2 2026; TTM through Jun 2026 was 4.1%, a 582.0% decrease from a year earlier, with the FY2025 full-year figure at 8.94%, up 24.0% from the prior year.
- FCF Margin was 6.52% for Q2 2026 at Amneal Pharmaceuticals, down from 4.83% in the prior quarter.
- The five-year high for FCF Margin was 23.32% in Q1 2023, with the low at 23.34% in Q2 2022.
- Average FCF Margin over 5 years is 6.37%, with a median of 9.83% recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: FCF Margin soared 2612 bps in 2023, then plunged 2539 bps in 2024.
- Over 5 years, FCF Margin stood at 5.7% in 2022, then jumped by 458 bps to 20.42% in 2023, then sank by 31 bps to 14.09% in 2024, then slipped by 5 bps to 13.33% in 2025, then sank by 149 bps to 6.52% in 2026.
- The last three FCF Margin figures came in at 6.52% (Q2 2026), 4.83% (Q1 2026), and 13.33% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 7.41% |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 8.76% |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 3.10% |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | -6.52% |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 20.79% |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 14.76% |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 20.15% |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 23.24% |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.52% |
| Mar 31, 2026 | -4.83% |
| Dec 31, 2025 | 13.33% |
| Sep 30, 2025 | 13.53% |
| Jun 30, 2025 | 8.42% |
| Mar 31, 2025 | -0.83% |
| Dec 31, 2024 | 14.09% |
| Sep 30, 2024 | 17.77% |
| Jun 30, 2024 | 4.14% |
| Mar 31, 2024 | -2.06% |
| Dec 31, 2023 | 20.42% |
| Sep 30, 2023 | 11.25% |
| Jun 30, 2023 | -3.90% |
| Mar 31, 2023 | 23.32% |
| Dec 31, 2022 | -5.70% |
| Sep 30, 2022 | 13.65% |
| Jun 30, 2022 | -23.34% |
| Mar 31, 2022 | 22.01% |
| Dec 31, 2021 | 8.52% |
| Sep 30, 2021 | 13.57% |